In breast cancer, pathogenic or likely pathogenic germline BRCA1 or BRCA2 variants are present in 6.1% of all cases [30–36], and 10–20% of triple-negative breast cancer cases [37]. This evidence concerns the gene BRCA2 and breast cancer.